Nuveen Asset Management’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-845,023
| Closed | -$43.7M | – | 3221 |
|
|
2022
Q3 | $43.7M | Sell |
845,023
-46,655
| -5% | -$2.41M | 0.02% | 571 |
|
|
2022
Q2 | $22.1M | Buy |
891,678
+332,802
| +60% | +$8.25M | 0.01% | 987 |
|
|
2022
Q1 | $13.6M | Buy |
558,876
+173,453
| +45% | +$4.22M | ﹤0.01% | 1448 |
|
|
2021
Q4 | $14M | Buy |
385,423
+178,325
| +86% | +$6.49M | ﹤0.01% | 1469 |
|
|
2021
Q3 | $3.54M | Sell |
207,098
-12,129
| -6% | -$207K | ﹤0.01% | 2398 |
|
|
2021
Q2 | $2.94M | Sell |
219,227
-253,488
| -54% | -$3.39M | ﹤0.01% | 2529 |
|
|
2021
Q1 | $24.2M | Buy |
472,715
+254,402
| +117% | +$13M | 0.01% | 1179 |
|
|
2020
Q4 | $1.76M | Sell |
218,313
-279,496
| -56% | -$2.25M | ﹤0.01% | 2572 |
|
|
2020
Q3 | $4.01M | Buy |
497,809
+63,428
| +15% | +$511K | ﹤0.01% | 2038 |
|
|
2020
Q2 | $3.5M | Sell |
434,381
-15,006
| -3% | -$121K | ﹤0.01% | 2083 |
|
|
2020
Q1 | $18.1M | Buy |
449,387
+58,534
| +15% | +$2.35M | 0.01% | 958 |
|
|
2019
Q4 | $15.5M | Buy |
390,853
+139,893
| +56% | +$5.53M | 0.01% | 1323 |
|
|
2019
Q3 | $1.7M | Sell |
250,960
-152,319
| -38% | -$1.03M | ﹤0.01% | 2478 |
|
|
2019
Q2 | $3.75M | Buy |
+403,279
| New | +$3.75M | ﹤0.01% | 2145 |
|